The North America infectious disease diagnostics market is expected to grow from US$ 8,921.15 million in 2021 to US$ 14,296.46 million by 2028; it is estimated to grow a CAGR of 7.0% from 2021 to 2028.

Infectious diseases are caused by infectious agents, including viruses, bacteria, parasites, fungi, and toxic products. HIV is a major public health problem across the region. As per the Joint United Nations Programme on HIV/AIDS (UNAIDS), ~37.7 million people had HIV in 2020, and out of these—1.7 million were children aged 0–14 years, 36 million were adults, and over half (53%) were girls and women. Furthermore, 1.5 million new HIV cases were reported in 2020. Similarly, hepatitis, inflammation of the liver, is caused by a viral infection. The five primary strains of hepatitis viruses are A, B, C, D, and E. As per World Health Organization (WHO), ~58 million people have chronic hepatitis C virus infection, while ~1.5 million new infections occur annually. According to WHO, tuberculosis (TB) is the thirteenth-leading cause of death and the second leading infectious disease after COVID-19. SARS-CoV-2 is a novel coronavirus that causes COVID-19. The COVID-19 outbreak is straining healthcare systems, increasing the need to develop diagnostic devices and service centers. Moreover, hospital-acquired infections or healthcare-associated infections (HAIs) have high morbidity and mortality rate. Also, such infections cost the healthcare system billions of dollars every year. Diagnostics play a vital role in determining the direction of any medical treatment of infectious diseases. Thus, the rising prevalence of infectious diseases propels the growth of the infectious disease diagnostics market.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America infectious disease diagnostics market at a notable CAGR during the forecast period.

North America Infectious Disease Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

North America Infectious Disease Diagnostics Market Segmentation

The North America infectious disease diagnostics market is segmented into product, technology, testing type, disease indication, end user, and country. Based on product, the North America infectious disease diagnostics market is segmented into kits & reagents, instruments, and software & services. The kits & reagents segment led the market in 2020; however, the software & services segment is likely to register the highest CAGR during the forecast period. Based on technology, the market is categorized into immunodiagnostics, polymerase chain reaction, next generation sequencing, clinical microbiology, and others. The next generation sequencing segment dominated the market in 2020, and it is expected to register the highest CAGR during the forecast period. Based on testing type, the market is divided into laboratory testing and point of care testing. The laboratory testing segment led the market in 2020; however, the point of care testing segment is likely to register a higher CAGR during the forecast period. Based on disease indication, the market is segmented into HIV, hepatitis, healthcare-associated infections, human papillomavirus, tuberculosis, influenza, and others. The hepatitis segment dominated the market in 2020; however, the healthcare-associated infections segment is expected to register the highest CAGR during the forecast period. Based on end user, the North America infectious disease diagnostics market is segmented into hospitals and clinics, pathology/diagnostic laboratories, research institutes, home care settings, and others. The pathology/diagnostic laboratories segment dominated the market in 2020; however, the home care settings segment is likely to register the highest CAGR during the forecast period. Based on country, the North America infectious disease diagnostics market is segmented into the US, Canada, and Mexico.

Abbott; AccuBioTech Co., Ltd.; ACON Laboratories, Inc.; BD; bioMerieux SA; BIO-RAD LABORATORIES INC.; Cardinal Health Inc; Danaher; F. HOFFMANN-LA ROCHE LTD.; and Trinity Biotechare are among the leading companies operating in the North America infectious disease diagnostics market.

TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Infectious Disease Diagnostics Market – By Product
1.3.2 North America Infectious Disease Diagnostics Market – By Technology
1.3.3 North America Infectious Disease Diagnostics Market – By Testing Type
1.3.4 North America Infectious Disease Diagnostics Market – By Disease Indication
1.3.5 North America Infectious Disease Diagnostics Market – By End User
1.3.6 North America Infectious Disease Diagnostics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Infectious Disease Diagnostics Market Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Infectious Disease Diagnostics Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Prevalence of Infectious Diseases
5.1.2 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Growing Opportunities in Developing Nations
5.4 Future Trend
5.4.1 Rising Number of Product Approvals and Launches
5.5 Impact Analysis
6. Infectious Disease Diagnostics Market– North America Analysis
6.1 North America Infectious Disease Diagnostics Market Revenue Forecast and Analysis
7. North America Infectious Disease Diagnostics Market Revenue and Forecast To 2028– by Product
7.1 Overview
7.2 North America by Product: Market Revenue and Forecast Analysis (US$ Million)
7.3 Kits and Reagents
7.3.1 Overview
7.3.2 Kits and Reagents Market Revenue and Forecast to 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market Revenue and Forecast to 2028 (US$ Million)
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services Market Revenue and Forecast to 2028 (US$ Million)
8. North America Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Technology
8.1 North America Infectious Disease Diagnostics Market Revenue Share, by Technology (2021 and 2028)
8.2 Immunodiagnostics
8.2.1 Overview
8.2.2 Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Polymerase Chain Reaction (PCR)
8.3.1 Overview
8.3.2 PCR: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Next Generation Sequencing
8.4.1 Overview
8.4.2 Next Generation Sequencing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Clinical Microbiology
8.5.1 Overview
8.5.2 Clinical Microbiology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Testing Type
9.1 North America Infectious Disease Diagnostics Market Revenue Share, by Testing Type (2021 and 2028)
9.2 Laboratory Testing
9.2.1 Overview
9.2.2 Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Point of Care Testing
9.3.1 Overview
9.3.2 Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Disease Indication
10.1 Overview
10.2 North America Infectious Disease Diagnostics Market Revenue Share, by Disease Indication (2021 and 2028)
10.3 HIV
10.3.1 Overview
10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)
10.4 Hepatitis
10.4.1 Overview
10.4.2 Hepatitis Market Revenue and Forecast to 2028 (US$ Million)
10.5 Healthcare Associated Infections (HAIs)
10.5.1 Overview
10.5.2 Hospital Associated Infections (HAIs) Market Revenue and Forecast to 2028 (US$ Million)
10.6 Human Papillomavirus (HPV)
10.6.1 Overview
10.6.2 Human Papillomavirus (HPV) Market Revenue and Forecast to 2028 (US$ Million)
10.7 Tuberculosis (TB)
10.7.1 Overview
10.7.2 Tuberculosis (TB) Market Revenue and Forecast to 2028 (US$ Million)
10.8 Influenza
10.8.1 Overview
10.8.2 Influenza Market Revenue and Forecast to 2028 (US$ Million)
10.9 Others
10.9.1 Overview
10.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)
11. North America Infectious Disease Diagnostics Market Analysis – by End User
11.1 Overview
11.2 North America Infectious Disease Diagnostics Market Revenue Share, by End User (2021 and 2028)
11.3 Hospitals and Clinics
11.3.1 Overview
11.3.2 Hospitals and Clinics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11.4 Pathology or Diagnostic Laboratories
11.4.1 Overview
11.4.2 Pathology or Diagnostics Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11.5 Research Institutes
11.5.1 Overview
11.5.2 Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11.6 Home Care Settings
11.6.1 Overview
11.6.2 Home Care Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11.7 Others
11.7.1 Overview
11.7.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12. North America Infectious Disease Diagnostics Market Revenue and Forecast to 2028 – Country Analysis
12.1 North America: Infectious Disease Diagnostics Market
12.1.1 Overview
12.1.3 North America: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)
12.1.3.1 US: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3.1.1 US: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3.1.2 US: Infectious Disease Diagnostics Market, by Product, 2019–2028 (US$ Million)
12.1.3.1.3 US: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (US$ Million)
12.1.3.1.4 US: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (US$ Million)
12.1.3.1.5 US: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (US$ Million)
12.1.3.1.6 US: Infectious Disease Diagnostics Market, by End User, 2019–2028 (US$ Million)
12.1.3.2 Canada: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3.2.1 Canada: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3.2.2 Canada: Infectious Disease Diagnostics Market, by Product, 2019–2028 (US$ Million)
12.1.3.2.3 Canada: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (US$ Million)
12.1.3.2.4 Canada: Infectious Disease Diagnostics Market, by Testing Type , 2019–2028 (US$ Million)
12.1.3.2.5 Canada: Infectious Disease Diagnostics Market, by Disease Indication , 2019–2028 (US$ Million)
12.1.3.2.6 Canada: Infectious Disease Diagnostics Market, by End User , 2019–2028 (US$ Million)
12.1.3.3 Mexico: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3.3.1 Mexico: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3.3.2 Mexico: Infectious Disease Diagnostics Market, by Product, 2019–2028 (US$ Million)
12.1.3.3.3 Mexico: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (US$ Million)
12.1.3.3.4 Mexico: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (US$ Million)
12.1.3.3.5 Mexico: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (US$ Million)
12.1.3.3.6 Mexico: Infectious Disease Diagnostics Market, by End User, 2019–2028 (US$ Million)
13. Industry Landscape
13.1 Overview
13.2 Organic Developments
13.2.1 Overview
13.3 Inorganic Developments
13.3.1 Overview
14. Company Profiles
14.1 Danaher
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Abbott
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 BD
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Trinity Biotech
14.4.1 1.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 F. HOFFMANN-LA ROCHE LTD.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Cardinal Health Inc.
14.6.1 1.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 bioMerieux SA
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 BIO-RAD LABORATORIES INC.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 AccuBioTech Co., Ltd.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 ACON Laboratories, Inc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners

LIST OF TABLES
Table 1. North America Infectious Disease Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
Table 2. US Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 3. US Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 4. US Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Organic Developments Done By Companies
Table 18. Inorganic Developments Done By Companies
Table 19. Glossary of Terms

LIST OF FIGURES
Figure 1. North America Infectious Disease Diagnostics Market Segmentation
Figure 2. North America Infectious Disease Diagnostics Market, By Country
Figure 3. North America Infectious Disease Diagnostics Market Overview
Figure 4. North America Infectious Disease Diagnostics Market, by Product
Figure 5. North America Infectious Disease Diagnostics Market, by Country
Figure 7. North America: PEST Analysis
Figure 8. Experts Opinion
Figure 9. North America Infectious Disease Diagnostics Market Impact Analysis of Drivers and Restraints
Figure 10. North America Infectious Disease Diagnostics Market– Revenue Forecast and Analysis
Figure 12. North America by Product: Market Analysis and Forecast 2021 and 2028 (%)
Figure 13. North America Kits and Reagents Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Instruments Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Software and Services Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Infectious Disease Diagnostics Market Revenue Share, by Technology (2021 and 2028)
Figure 17. North America Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America PCR: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Next Generation Sequencing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. North America Clinical Microbiology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Infectious Disease Diagnostics Market Revenue Share, by Testing Type (2021 and 2028)
Figure 23. North America Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. North America Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America Infectious Disease Diagnostics Market Revenue Share, by Disease Indication (2021 and 2028)
Figure 26. North America HIV Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America Hepatitis Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America Hospital Associated Infections (HAIs) Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America Human Papillomavirus (HPV) Market Revenue and Forecast to 2028 (US$ Million)
Figure 30. North America Tuberculosis (TB) Market Revenue and Forecast to 2028 (US$ Million)
Figure 31. North America Influenza Market Revenue and Forecast to 2028 (US$ Million)
Figure 32. North America Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 33. North America Infectious Disease Diagnostics Market Revenue Share, by End User (2021 and 2028)
Figure 34. North America Hospitals: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. North America Pathology or Diagnostics Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. North America Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. North America Home Care Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. North America Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. North America: Infectious Disease Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 40. North America: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 41. US: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Canada: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Mexico: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America infectious disease diagnostics market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the North America infectious disease diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the infectious disease diagnostics market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – North America Infectious Disease Diagnostics Market

● Abbott
● AccuBioTech Co., Ltd.
● ACON Laboratories, Inc.
● BD
● bioMerieux SA
● BIO-RAD LABORATORIES INC.
● Cardinal Health Inc
● Danaher
● F. HOFFMANN-LA ROCHE LTD.
● Trinity Biotech